nach oben

Reactions Weekly

Erschienen in:

01.08.2019 | Case report

Bupropion/mirtazapine

Recurrent isolated sleep paralysis, seizure and weight gain: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 15-year-old girl developed recurrent isolated sleep paralysis following abrupt discontinuation of bupriopion (rebound effect) during treatment for major depressive disorder. Additionally, she also developed seizure during treatment with bupropion and weight gain and exacerbation of rebound effect during treatment with mirtazapine for major depression disorder [not all durations of treatment to reactions onset stated; routes and frequencies not stated]. …

Bieber ED, et al. Recurrent isolated sleep paralysis following bupropion cessation: A case report. Journal of Clinical Psychopharmacology 39: 407-409, No. 4, Jul-Aug 2019. Available from: URL: http://doi.org/10.1097/JCP.0000000000001051 -USA

Titel: Bupropion/mirtazapine
Recurrent isolated sleep paralysis, seizure and weight gain: case report
Publikationsdatum: 01.08.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-65842-7

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Bupropion/mirtazapine

Recurrent isolated sleep paralysis, seizure and weight gain: case report

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Botulinum toxin A

Palbociclib

Azathioprine/methylprednisolone

Bcg

Escitalopram/trazodone

Prednisolone/tacrolimus